These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11571498)

  • 1. Impaired phospholipid-related signal transduction in advanced Huntington's disease.
    Puri BK
    Exp Physiol; 2001 Sep; 86(5):683-5. PubMed ID: 11571498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal phospholipid-related signal transduction in autism.
    Puri BK; Singh I
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1405-7. PubMed ID: 12502030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The niacin skin flush test in schizophrenia: a replication study.
    Puri BK; Easton T; Das I; Kidane L; Richardson AJ
    Int J Clin Pract; 2001; 55(6):368-70. PubMed ID: 11501224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia.
    Puri BK; Hirsch SR; Easton T; Richardson AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):49-52. PubMed ID: 11853118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study.
    Messamore E; Hoffman WF; Janowsky A
    Schizophr Res; 2003 Aug; 62(3):251-8. PubMed ID: 12837522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niacin skin flush test: a research tool for studying schizophrenia.
    Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
    Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia.
    Smesny S; Rosburg T; Riemann S; Baur K; Rudolph N; Berger G; Sauer H
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):393-402. PubMed ID: 15885994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niacin skin test response in dyslexia.
    Cyhlarova E; Montgomery P; Ross MA; Richardson AJ
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):123-8. PubMed ID: 17890071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia.
    Messamore E
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):413-9. PubMed ID: 14623495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
    Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
    Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin skin flush is not diagnostic of schizophrenia.
    Wilson DW; Douglass AB
    Biol Psychiatry; 1986 Aug; 21(10):974-7. PubMed ID: 3741914
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymorphisms in PLA2G6 and PLA2G4C genes for calcium-independent phospholipase A2 do not contribute to attenuated niacin skin flush response in schizophrenia patients.
    Nadalin S; Radović I; Buretić-Tomljanović A
    Prostaglandins Leukot Essent Fatty Acids; 2015 Sep; 100():29-32. PubMed ID: 26160611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial.
    Huntington Study Group Reach2HD Investigators
    Lancet Neurol; 2015 Jan; 14(1):39-47. PubMed ID: 25467848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niacin skin flush in schizophrenia: a preliminary report.
    Ward PE; Sutherland J; Glen EM; Glen AI
    Schizophr Res; 1998 Feb; 29(3):269-74. PubMed ID: 9516668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association between niacin skin flush response and plasma triglyceride levels in patients with schizophrenia.
    Nadalin S; Jonovska S; Šendula Jengić V; Buretić-Tomljanović A
    Prostaglandins Leukot Essent Fatty Acids; 2020 Apr; 155():102084. PubMed ID: 32126479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans.
    Morrow JD; Awad JA; Oates JA; Roberts LJ
    J Invest Dermatol; 1992 May; 98(5):812-5. PubMed ID: 1373750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive and mnemonic functions in early Huntington's disease.
    Lawrence AD; Sahakian BJ; Hodges JR; Rosser AE; Lange KW; Robbins TW
    Brain; 1996 Oct; 119 ( Pt 5)():1633-45. PubMed ID: 8931586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disturbance of real space navigation in moderately advanced but not in early Huntington's disease.
    Majerová V; Kalinčík T; Laczó J; Vyhnálek M; Hort J; Bojar M; Růžička E; Roth J
    J Neurol Sci; 2012 Jan; 312(1-2):86-91. PubMed ID: 21875725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease.
    Henderson T; Georgiou-Karistianis N; White O; Millist L; Williams DR; Churchyard A; Fielding J
    Mov Disord; 2011 Aug; 26(10):1893-9. PubMed ID: 21630355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol synthesis in cultured skin fibroblasts from patients with Huntington's disease.
    Maltese WA
    Biochem Med; 1984 Aug; 32(1):144-50. PubMed ID: 6238592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.